Professor Christoph Gerber of the Swiss Nanoscience Institute and the Department of Physics at the University of Basel has been selected as the winner of the Albert Einstein World Award of Science. The World Cultural Council awarded Gerber the prize in recognition of the fundamental nature and broad applicability of his research on Nanoscale Science.
Bacteria harness the power of communities. A research group at the University of Basel has now discovered that the bacterial pathogen that causes cholera forms a novel type of bacterial community on immune cells: an aggressive biofilm that is lethal for the cells. The study, recently published in the journal Cell, provides new insights into the infection strategies of pathogens.
Meat, milk, labor: domestic cattle have a lot to offer. Their history is consequently closely intertwined with that of humankind. Researchers at the University of Basel have investigated the genetic development of this livestock animal in Switzerland, and it is linked with societal developments.
Breast cancer spreading to other organs usually heralds a poorer prognosis. Researchers at the University and University Hospital of Basel have discovered a process that helps breast cancer cells implant themselves in certain places in the body. The results suggest a way of preventing secondary tumors.
Receptor proteins serve as the “eyes and ears” of the cell. The largest receptor family are the so-called G protein-coupled receptors. They respond to highly diverse stimuli ranging from photons to hormones and odorants. Researchers at the University of Basel have discovered a unique recognition pattern that works like a barcode and tags the receptor for desensitization. By this mechanism, signaling in cells is rapidly switched off when it is no longer needed.
Lorenza Mondada, Professor of French and General Linguistics at the University of Basel, has received an honorary doctorate from the University of Helsinki in recognition of her scholarly work.
Nanomedicine involves packaging drugs in microscopic particles to make them more effective. Nanopharmacy professor Scott McNeil explains the opportunities presented by the new technology and what is still holding it back: approval procedures, for example, as seen in the inconsistent approach taken with the Covid-19 vaccines.
For the fifth time, the University of Basel has recognized outstanding achievements in the field of teaching with the Teaching Excellence Awards. Participation was strong: altogether, a total of 549 nominations of 213 lecturers were submitted in the five categories.
In March 2022, Microsoft published research results about the realisation of a special type of particle that might be used to make particularly robust quantum bits. Researchers at the University of Basel are now calling these results about so-called Majorana particles into doubt: through calculations they have shown that the findings can also be explained differently.
